Fund Holdings — Frazier Life Sciences Management, L.P.

Total Portfolio Value:
$2.50B
Total Bought:
$443.95M
Total Sold:
$90.69M
Net Transaction:
+$353.26M
Notable People:
James Newman Topper, Patrick James Heron, Daniel Estes, James Brush, Albert (Nmn) Cha, Frazier Life Sciences Management,
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Mirum Pharmaceuticals, Inc.(MIRM)6,495,3926,570,392+75,000$222.08M$256.25M10.27%+$34.17M
Newamsterdam Pharma Company
ORDINARY SHARES
12,226,94312,855,194+628,251$234.88M$213.40M8.55%-$21.48M
Phathom Pharmaceuticals, Inc.(PHAT)10,109,27910,109,2790$104.13M$182.78M7.33%+$78.65M
Krystal Biotech, Inc.(KRYS)988,460988,4600$181.52M$179.93M7.21%-$1.59M
MBX Biosciences, Inc.(MBX)05,985,347+5,985,347$0$155.50M6.23%+$155.50M
Rhythm Pharmaceuticals, Inc.(RYTM)2,371,3042,416,952+45,648$97.37M$126.62M5.08%+$29.26M
Vaxcyte, Inc.(PCVX)1,039,405879,405-160,000$78.49M$100.49M4.03%+$22.00M
Verona Pharma PlcADS3,314,3493,383,950+69,601$47.93M$97.36M3.90%+$49.43M
BridgeBio Pharma, Inc.(BBIO)3,632,6043,760,457+127,853$92.01M$95.74M3.84%+$3.73M
Disc Medicine, Inc.(IRON)1,754,8341,754,8340$79.09M$86.23M3.46%+$7.14M
Arcutis Biotherapeutics, Inc.(ARQT)8,785,2848,785,2840$81.70M$81.70M3.27%$0
Edgewise Therapeutics, Inc.(EWTX)3,731,0672,832,867-898,200$67.20M$75.61M3.03%+$8.41M
Anaptysbio Inc2,165,5912,209,189+43,598$54.27M$74.01M2.97%+$19.74M
Erasca, Inc.(ERAS)16,216,21619,391,687+3,175,471$38.27M$52.94M2.12%+$14.67M
Tarsus Pharmaceuticals, Inc.(TARS)1,587,5271,587,5270$43.15M$52.21M2.09%+$9.06M
Agios Pharmaceuticals, Inc.(AGIO)871,9741,044,154+172,180$37.60M$46.39M1.86%+$8.79M
Revolution Medicines, Inc.(RVMD)997,455997,4550$38.71M$45.23M1.81%+$6.52M
Soleno Therapeutics Inc875,667875,6670$35.73M$44.21M1.77%+$8.49M
Kalvista Pharmaceuticals Inc3,687,8673,687,8670$43.44M$42.71M1.71%-$737.6K
ORIC Pharmaceuticals, Inc.(ORIC)4,142,8554,142,8550$29.29M$42.46M1.70%+$13.17M
Ultragenyx Pharmaceutical Inc.(RARE)425,000633,715+208,715$17.47M$35.20M1.41%+$17.74M
Savara Inc.(SVRA)8,157,3858,157,3850$32.87M$34.59M1.39%+$1.71M
CG Oncology, Inc.(CGON)770,000770,0000$24.31M$29.05M1.16%+$4.74M
Rocket Pharmaceuticals, Inc.(RCKT)1,561,2301,485,630-75,600$33.61M$27.44M1.10%-$6.17M
Trevi Therapeutics, Inc.(TRVI)7,381,0907,381,0900$22.00M$24.65M0.99%+$2.66M
Mereo BioPharma Group plcADS(MREO)4,401,3715,097,779+696,408$15.84M$20.95M0.84%+$5.11M
Silence Therapeutics plcADS(SLN)1,148,5911,148,5910$21.82M$20.88M0.84%-$941.8K
Ascendis Pharma A/SADR(ASND)0133,333+133,333$0$19.91M0.80%+$19.91M
Hillevax Inc10,617,06210,617,0620$153.52M$18.69M0.75%-$134.84M
Merus N V373,100373,1000$22.08M$18.64M0.75%-$3.44M
Tyra Biosciences, Inc.(TYRA)832,220731,020-101,200$13.31M$17.19M0.69%+$3.88M
Autolus Therapeutics plcADS(AUTL)4,623,3244,623,3240$16.09M$16.78M0.67%+$693.5K
Alkermes plcSHS(ALKS)0576,129+576,129$0$16.13M0.65%+$16.13M
Immatics N.V.SHS(IMTX)1,152,4561,354,711+202,255$13.39M$15.46M0.62%+$2.07M
Oruka Therapeutics, Inc.(ORKA)0477,327+477,327$0$11.70M0.47%+$11.70M
Lexeo Therapeutics, Inc.(LXEO)01,250,786+1,250,786$0$11.31M0.45%+$11.31M
Design Therapeutics, Inc.(DSGN)1,195,1791,892,547+697,368$4.00M$10.18M0.41%+$6.18M
Cogent Biosciences, Inc.(COGT)936,576936,5760$7.90M$10.12M0.41%+$2.22M
MacroGenics, Inc.(MGNX)3,010,7273,010,7270$12.80M$9.91M0.40%-$2.89M
Day One Biopharmaceuticals I
COM
0689,655+689,655$0$9.61M0.39%+$9.61M
Allogene Therapeutics Inc2,867,7502,867,7500$6.68M$8.03M0.32%+$1.35M
Puma Biotechnology, Inc.(PBYI)3,062,5583,062,5580$9.98M$7.81M0.31%-$2.17M
Adverum Biotechnologies Inc1,069,2441,069,2440$7.34M$7.51M0.30%+$171.1K
89bio Inc1,000,0001,000,0000$8.01M$7.40M0.30%-$610.0K
Acadia Pharmaceuticals Inc470,338470,3380$7.64M$7.23M0.29%-$409.2K
Arvinas, Inc.(ARVN)285,331285,3310$7.60M$7.03M0.28%-$567.8K
PepGen Inc.(PEPG)1,502,788702,694-800,094$23.98M$6.01M0.24%-$17.98M
Elevation Oncology Inc2,958,5795,993,579+3,035,000$7.99M$3.60M0.14%-$4.39M
Newamsterdam Pharma CompanyW EXP 11 22 202
*W EXP 99/99/999
500,333500,3330$4.36M$3.50M0.14%-$860.6K
Immunocore Holdings plcADS(IMCR)108,762108,7620$3.69M$3.39M0.14%-$300.2K
Nuvation Bio Inc.CL A(NUVB)01,218,236+1,218,236$0$2.79M0.11%+$2.79M
Aclaris Therapeutics, Inc.(ACRS)264,377264,3770$290.8K$304.0K0.01%+$13.2K
Pieris Pharmaceuticals Inc015,942+15,942$0$266.9K0.01%+$266.9K
An2 Therapeutics Inc2,088,8890-2,088,889$4.49M$0—-$4.49M
Applied Therapeutics Inc2,286,1350-2,286,135$10.68M$0—-$10.68M
Cerevel Therapeutics Hldng I393,0000-393,000$16.07M$0—-$16.07M
Metagenomi Therapeutics, Inc.(MGX)245,6920-245,692$1.00M$0—-$1.00M
Page 1 of 1
Frazier Life Sciences Management, L.P. — 13F Holdings — Q3 2024 | TickerTrail